Mastocytosis: oral implications of a rare disease.
Identifieur interne : 000318 ( Main/Exploration ); précédent : 000317; suivant : 000319Mastocytosis: oral implications of a rare disease.
Auteurs : T A Rama [Portugal] ; I. Côrte-Real ; P S Gomes ; L. Escribano ; M H FernandesSource :
- Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology [ 1600-0714 ] ; 2011.
Descripteurs français
- KwdFr :
- Anaphylaxie (étiologie), Dégranulation cellulaire (MeSH), Humains (MeSH), Libération d'histamine (MeSH), Maladies de la mâchoire (anatomopathologie), Maladies parodontales (anatomopathologie), Mastocytose (anatomopathologie), Mastocytose (complications), Mastocytose (génétique), Médiateurs de l'inflammation (métabolisme), Protéines proto-oncogènes c-kit (génétique), Pulpite (anatomopathologie), Soins dentaires pour malades chroniques (MeSH).
- MESH :
- anatomopathologie : Maladies de la mâchoire, Maladies parodontales, Mastocytose, Pulpite.
- génétique : Mastocytose, Protéines proto-oncogènes c-kit.
- métabolisme : Médiateurs de l'inflammation.
- étiologie : Anaphylaxie.
- Dégranulation cellulaire, Humains, Libération d'histamine, Soins dentaires pour malades chroniques.
English descriptors
- KwdEn :
- Anaphylaxis (etiology), Cell Degranulation (MeSH), Dental Care for Chronically Ill (MeSH), Histamine Release (MeSH), Humans (MeSH), Inflammation Mediators (metabolism), Jaw Diseases (pathology), Mastocytosis (complications), Mastocytosis (genetics), Mastocytosis (pathology), Periodontal Diseases (pathology), Proto-Oncogene Proteins c-kit (genetics), Pulpitis (pathology).
- MESH :
- chemical , genetics : Proto-Oncogene Proteins c-kit.
- chemical , metabolism : Inflammation Mediators.
- complications : Mastocytosis.
- etiology : Anaphylaxis.
- genetics : Mastocytosis.
- pathology : Jaw Diseases, Mastocytosis, Periodontal Diseases, Pulpitis.
- Cell Degranulation, Dental Care for Chronically Ill, Histamine Release, Humans.
Abstract
Mastocytosis encompasses a group of rare clinical entities, which are characterized by an abnormal growth and, usually, low accumulation of clonal and morphologically abnormal mast cells (MCs), within one or more organs. Clinical presentations are quite variable and symptoms are usually related to the release of mast cell mediators, tissue infiltration by MC (usually in the aggressive categories of the disease), or both. Mast cells are hematopoietic-derived cells that reach phenotypic maturity in the mucosa and peripheral connective tissues. These cells play an active role both on immunologic and non-immunologic processes. Within the oral cavity, MCs reside in the connective tissues, in physiologic conditions, and their number is elevated in pathologic situations resulting from immunoinflammatory processes, such as pulpal inflammation and periodontal disease. As MCs influence so many phenomena within the oral cavity, mastocytosis may manifest itself in the oral tissues. Patients with mastocytosis should be put under special care by dental professionals, in what concerns not only general patient management, but also drug prescription, as they are particularly prone to anaphylaxis and other peri and post-operative complications. Several allergens or mast cell activation triggers such as local anesthetics, zinc oxide, eugenol, penicilins, metals and oral hygiene products are frequently administered or prescribed by dentists. Patients with mastocytosis may also require stress management, during dental consultation. This review aims to briefly summarize the potential ways in which mast cell disease may affect the oral cavity and the dental management of mastocytosis affected patients.
DOI: 10.1111/j.1600-0714.2010.00996.x
PubMed: 21198873
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Mastocytosis: oral implications of a rare disease.</title><author><name sortKey="Rama, T A" sort="Rama, T A" uniqKey="Rama T" first="T A" last="Rama">T A Rama</name><affiliation wicri:level="1"><nlm:affiliation>Laboratório de Farmacologia e Biocompatibilidade Celular, Faculdade de Medicina Dentária, Universidade do Porto, Portugal.</nlm:affiliation><country xml:lang="fr">Portugal</country><wicri:regionArea>Laboratório de Farmacologia e Biocompatibilidade Celular, Faculdade de Medicina Dentária, Universidade do Porto</wicri:regionArea><wicri:noRegion>Universidade do Porto</wicri:noRegion></affiliation></author><author><name sortKey="Corte Real, I" sort="Corte Real, I" uniqKey="Corte Real I" first="I" last="Côrte-Real">I. Côrte-Real</name></author><author><name sortKey="Gomes, P S" sort="Gomes, P S" uniqKey="Gomes P" first="P S" last="Gomes">P S Gomes</name></author><author><name sortKey="Escribano, L" sort="Escribano, L" uniqKey="Escribano L" first="L" last="Escribano">L. Escribano</name></author><author><name sortKey="Fernandes, M H" sort="Fernandes, M H" uniqKey="Fernandes M" first="M H" last="Fernandes">M H Fernandes</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21198873</idno><idno type="pmid">21198873</idno><idno type="doi">10.1111/j.1600-0714.2010.00996.x</idno><idno type="wicri:Area/Main/Corpus">000325</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000325</idno><idno type="wicri:Area/Main/Curation">000325</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000325</idno><idno type="wicri:Area/Main/Exploration">000325</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Mastocytosis: oral implications of a rare disease.</title><author><name sortKey="Rama, T A" sort="Rama, T A" uniqKey="Rama T" first="T A" last="Rama">T A Rama</name><affiliation wicri:level="1"><nlm:affiliation>Laboratório de Farmacologia e Biocompatibilidade Celular, Faculdade de Medicina Dentária, Universidade do Porto, Portugal.</nlm:affiliation><country xml:lang="fr">Portugal</country><wicri:regionArea>Laboratório de Farmacologia e Biocompatibilidade Celular, Faculdade de Medicina Dentária, Universidade do Porto</wicri:regionArea><wicri:noRegion>Universidade do Porto</wicri:noRegion></affiliation></author><author><name sortKey="Corte Real, I" sort="Corte Real, I" uniqKey="Corte Real I" first="I" last="Côrte-Real">I. Côrte-Real</name></author><author><name sortKey="Gomes, P S" sort="Gomes, P S" uniqKey="Gomes P" first="P S" last="Gomes">P S Gomes</name></author><author><name sortKey="Escribano, L" sort="Escribano, L" uniqKey="Escribano L" first="L" last="Escribano">L. Escribano</name></author><author><name sortKey="Fernandes, M H" sort="Fernandes, M H" uniqKey="Fernandes M" first="M H" last="Fernandes">M H Fernandes</name></author></analytic><series><title level="j">Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology</title><idno type="eISSN">1600-0714</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anaphylaxis (etiology)</term><term>Cell Degranulation (MeSH)</term><term>Dental Care for Chronically Ill (MeSH)</term><term>Histamine Release (MeSH)</term><term>Humans (MeSH)</term><term>Inflammation Mediators (metabolism)</term><term>Jaw Diseases (pathology)</term><term>Mastocytosis (complications)</term><term>Mastocytosis (genetics)</term><term>Mastocytosis (pathology)</term><term>Periodontal Diseases (pathology)</term><term>Proto-Oncogene Proteins c-kit (genetics)</term><term>Pulpitis (pathology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anaphylaxie (étiologie)</term><term>Dégranulation cellulaire (MeSH)</term><term>Humains (MeSH)</term><term>Libération d'histamine (MeSH)</term><term>Maladies de la mâchoire (anatomopathologie)</term><term>Maladies parodontales (anatomopathologie)</term><term>Mastocytose (anatomopathologie)</term><term>Mastocytose (complications)</term><term>Mastocytose (génétique)</term><term>Médiateurs de l'inflammation (métabolisme)</term><term>Protéines proto-oncogènes c-kit (génétique)</term><term>Pulpite (anatomopathologie)</term><term>Soins dentaires pour malades chroniques (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Proto-Oncogene Proteins c-kit</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Inflammation Mediators</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Maladies de la mâchoire</term><term>Maladies parodontales</term><term>Mastocytose</term><term>Pulpite</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Mastocytosis</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Anaphylaxis</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Mastocytosis</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Mastocytose</term><term>Protéines proto-oncogènes c-kit</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Médiateurs de l'inflammation</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Jaw Diseases</term><term>Mastocytosis</term><term>Periodontal Diseases</term><term>Pulpitis</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Anaphylaxie</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cell Degranulation</term><term>Dental Care for Chronically Ill</term><term>Histamine Release</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Dégranulation cellulaire</term><term>Humains</term><term>Libération d'histamine</term><term>Soins dentaires pour malades chroniques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Mastocytosis encompasses a group of rare clinical entities, which are characterized by an abnormal growth and, usually, low accumulation of clonal and morphologically abnormal mast cells (MCs), within one or more organs. Clinical presentations are quite variable and symptoms are usually related to the release of mast cell mediators, tissue infiltration by MC (usually in the aggressive categories of the disease), or both. Mast cells are hematopoietic-derived cells that reach phenotypic maturity in the mucosa and peripheral connective tissues. These cells play an active role both on immunologic and non-immunologic processes. Within the oral cavity, MCs reside in the connective tissues, in physiologic conditions, and their number is elevated in pathologic situations resulting from immunoinflammatory processes, such as pulpal inflammation and periodontal disease. As MCs influence so many phenomena within the oral cavity, mastocytosis may manifest itself in the oral tissues. Patients with mastocytosis should be put under special care by dental professionals, in what concerns not only general patient management, but also drug prescription, as they are particularly prone to anaphylaxis and other peri and post-operative complications. Several allergens or mast cell activation triggers such as local anesthetics, zinc oxide, eugenol, penicilins, metals and oral hygiene products are frequently administered or prescribed by dentists. Patients with mastocytosis may also require stress management, during dental consultation. This review aims to briefly summarize the potential ways in which mast cell disease may affect the oral cavity and the dental management of mastocytosis affected patients.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21198873</PMID><DateCompleted><Year>2011</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2011</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1600-0714</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>6</Issue><PubDate><Year>2011</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology</Title><ISOAbbreviation>J Oral Pathol Med</ISOAbbreviation></Journal><ArticleTitle>Mastocytosis: oral implications of a rare disease.</ArticleTitle><Pagination><MedlinePgn>441-50</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1600-0714.2010.00996.x</ELocationID><Abstract><AbstractText>Mastocytosis encompasses a group of rare clinical entities, which are characterized by an abnormal growth and, usually, low accumulation of clonal and morphologically abnormal mast cells (MCs), within one or more organs. Clinical presentations are quite variable and symptoms are usually related to the release of mast cell mediators, tissue infiltration by MC (usually in the aggressive categories of the disease), or both. Mast cells are hematopoietic-derived cells that reach phenotypic maturity in the mucosa and peripheral connective tissues. These cells play an active role both on immunologic and non-immunologic processes. Within the oral cavity, MCs reside in the connective tissues, in physiologic conditions, and their number is elevated in pathologic situations resulting from immunoinflammatory processes, such as pulpal inflammation and periodontal disease. As MCs influence so many phenomena within the oral cavity, mastocytosis may manifest itself in the oral tissues. Patients with mastocytosis should be put under special care by dental professionals, in what concerns not only general patient management, but also drug prescription, as they are particularly prone to anaphylaxis and other peri and post-operative complications. Several allergens or mast cell activation triggers such as local anesthetics, zinc oxide, eugenol, penicilins, metals and oral hygiene products are frequently administered or prescribed by dentists. Patients with mastocytosis may also require stress management, during dental consultation. This review aims to briefly summarize the potential ways in which mast cell disease may affect the oral cavity and the dental management of mastocytosis affected patients.</AbstractText><CopyrightInformation>© 2010 John Wiley & Sons A/S.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rama</LastName><ForeName>T A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Laboratório de Farmacologia e Biocompatibilidade Celular, Faculdade de Medicina Dentária, Universidade do Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Côrte-Real</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>P S</ForeName><Initials>PS</Initials></Author><Author ValidYN="Y"><LastName>Escribano</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Fernandes</LastName><ForeName>M H</ForeName><Initials>MH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>J Oral Pathol Med</MedlineTA><NlmUniqueID>8911934</NlmUniqueID><ISSNLinking>0904-2512</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D019009">Proto-Oncogene Proteins c-kit</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000707" MajorTopicYN="N">Anaphylaxis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015550" MajorTopicYN="N">Cell Degranulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017742" MajorTopicYN="Y">Dental Care for Chronically Ill</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006636" MajorTopicYN="N">Histamine Release</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="N">Inflammation Mediators</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007571" MajorTopicYN="N">Jaw Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008415" MajorTopicYN="N">Mastocytosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010510" MajorTopicYN="N">Periodontal Diseases</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019009" MajorTopicYN="N">Proto-Oncogene Proteins c-kit</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011671" MajorTopicYN="N">Pulpitis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>11</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21198873</ArticleId><ArticleId IdType="doi">10.1111/j.1600-0714.2010.00996.x</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Portugal</li></country></list><tree><noCountry><name sortKey="Corte Real, I" sort="Corte Real, I" uniqKey="Corte Real I" first="I" last="Côrte-Real">I. Côrte-Real</name><name sortKey="Escribano, L" sort="Escribano, L" uniqKey="Escribano L" first="L" last="Escribano">L. Escribano</name><name sortKey="Fernandes, M H" sort="Fernandes, M H" uniqKey="Fernandes M" first="M H" last="Fernandes">M H Fernandes</name><name sortKey="Gomes, P S" sort="Gomes, P S" uniqKey="Gomes P" first="P S" last="Gomes">P S Gomes</name></noCountry><country name="Portugal"><noRegion><name sortKey="Rama, T A" sort="Rama, T A" uniqKey="Rama T" first="T A" last="Rama">T A Rama</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000318 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000318 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21198873
|texte= Mastocytosis: oral implications of a rare disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21198873" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |